molecular€pathobiology€of lung€canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf ·...
TRANSCRIPT
![Page 1: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/1.jpg)
Molecular Pathobiology ofLung Cancer
William K. Funkhouser, MD PhDDepartment of Pathology and Lab Medicine
University of North Carolina
![Page 2: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/2.jpg)
Outline
•Lung Anatomy•Lung Carcinoma Classification & Morphology•Lung Carcinoma Epidemiology•Associated Molecular Abnormalities/Targets
![Page 3: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/3.jpg)
![Page 4: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/4.jpg)
Bronchial Wall
![Page 5: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/5.jpg)
Bronchial Mucosa
![Page 6: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/6.jpg)
![Page 7: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/7.jpg)
Lobule Architecture
![Page 8: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/8.jpg)
Bronchiolar Wall
![Page 9: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/9.jpg)
![Page 10: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/10.jpg)
Alveolar Septae
![Page 11: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/11.jpg)
Neoplasms Involving the Lung
•Primary Neoplasms of Lung•Metastatic Neoplasms to Lung
![Page 12: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/12.jpg)
Primary Neoplasms of Lung:Classification by Lineage
•Epithelial –most common•Melanocytic•Stromal
![Page 13: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/13.jpg)
Malignant epithelial neoplasms(Carcinomas)
Classification and Morphology
•Squamous cell carcinoma•Adenocarcinoma•Large cell undifferentiated carcinoma•Small cell undifferentiated carcinoma
![Page 14: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/14.jpg)
Squamous cell carcinoma
•Clin: Smokers (98%)2030% of common carcinomas
•Rad: central > > peripheral
•Path: Bronchi > Larynx > Trachea+/ Desmosomes (intercellular bridges)+/ Keratin production, e.g. keratin pearls
![Page 15: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/15.jpg)
Normal
![Page 16: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/16.jpg)
Adapted from Slide Atlas, Diagnostic Oncology, ed. AT Skarin, Gower Med Publ, 1992
Squamous cell carcinoma
![Page 17: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/17.jpg)
Squamous cell carcinoma
![Page 18: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/18.jpg)
Squamous cell carcinoma in situRespiratory mucosa
![Page 19: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/19.jpg)
Invasive Squamous Carcinoma
Keratin
Desmosomes
![Page 20: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/20.jpg)
Metastatic squamous cell carcinoma to lymph node
Normal lymph node lymphocytes
Mets in subcapsular sinuses
![Page 21: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/21.jpg)
Adenocarcinoma
•Clin: 3040% of common carcinomasMost common carcinoma in nonsmokers
•Rad: peripheral > central
•Path: +/ glands+/ mucinBronchioloalveolar carcinoma subset
![Page 22: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/22.jpg)
Adenocarcinoma
Primary
Pleural effusion
Adapted from Slide Atlas, Diagnostic Oncology, ed. AT Skarin, Gower Med Publ, 1992
![Page 23: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/23.jpg)
Adenocarcinoma
Gland formation
![Page 24: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/24.jpg)
Adenocarcinoma
Mucin production (red on PASd stain)
![Page 25: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/25.jpg)
Bronchioloalveolar carcinoma(BAC)
•Clin: 2025% of adenocarcinomasNot associated with cigarette smoking
•Rad: Peripheral, can be multifocal and bilat•Path: Lepidic (butterflylike) growth pattern
Mucinous or nonmucinousUnifocal or multifocalDistinction of multifocal 1° from mets
![Page 26: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/26.jpg)
Bronchioloalveolar carcinoma
Adapted from Slide Atlas, Diagnostic Oncology, ed. AT Skarin, Gower Med Publ, 1992
Multiple, bilateral pulmonary nodules
![Page 27: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/27.jpg)
Bronchioloalveolar carcinoma
![Page 28: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/28.jpg)
Bronchioloalveolar carcinoma
![Page 29: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/29.jpg)
Large cell undifferentiatedcarcinoma
•Clin: 10% of common carcinomas•Rad: nonspecific•Path: H&E: Undifferentiated
No squamous or adeno featuresNo neuroendocrine features
![Page 30: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/30.jpg)
Large cell undifferentiated carcinoma
Adapted from Slide Atlas, Diagnostic Oncology, ed. AT Skarin, Gower Med Publ, 1992
![Page 31: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/31.jpg)
Large cell undifferentiated carcinoma
![Page 32: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/32.jpg)
NonSmall Cell Lung Carcinomas:Prognostic variables
•Definitely: Stage (local, nodes, distant mets),performance status, weight loss
•Definitely not: Age, histology
![Page 33: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/33.jpg)
Small cell (undifferentiated) carcinoma
• Clin: SmokersCa. 20% of common carcinomasEctopic hormones (e.g. ACTH, ADH)Commonly high stage at presentationResponsive to chemo/RT, but low 5 yr survival
• Rad: Central in >90%Frequent metastases to LNs and distant sites
• Path: Malignant cytologyNo nucleoliHigh mitotic activity and necrosis
![Page 34: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/34.jpg)
Small cell carcinoma
At diagnosisResponse toChemo/radiotherapy
Adapted from Slide Atlas, Diagnostic Oncology, ed. AT Skarin, Gower Med Publ, 1992
![Page 35: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/35.jpg)
Small cell carcinoma
Viable carcinoma
Necroticcarcinoma
![Page 36: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/36.jpg)
Small cell carcinoma
![Page 37: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/37.jpg)
Small cell carcinoma
![Page 38: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/38.jpg)
Metastatic small cell carcinomaNormal lymphocytes
![Page 39: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/39.jpg)
Small Cell Lung Carcinoma:Prognostic variables
•Definitely: Stage, performance status
•Probably: Gender, age, # of metastaticsites
![Page 40: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/40.jpg)
Malignant epithelial neoplasms(Carcinomas)
•Squamous cell carcinoma•Adenocarcinoma•Large cell undifferentiated carcinoma•Small cell undifferentiated carcinoma
![Page 41: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/41.jpg)
Metastatic Neoplasms to Lung
•Most common malignant neoplasmsinvolving the lung
•Multiple nodules favor metastases overprimary neoplasms (except BAC)
•Carcinomas•Sarcomas•Melanoma
![Page 42: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/42.jpg)
Metastatic carcinomas
•Breast adenoCA•GI adenoCA•Renal adenoCA•Head/neck squamous cell CA
![Page 43: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/43.jpg)
Metastatic breast carcinoma
![Page 44: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/44.jpg)
Metastatic colon carcinoma
![Page 45: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/45.jpg)
Metastaticrenal cellcarcinoma
![Page 46: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/46.jpg)
MetastaticENTcarcinoma
![Page 47: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/47.jpg)
Metastatic sarcomas
•Osteosarcomas•Soft tissue sarcomas
![Page 48: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/48.jpg)
Metastatic Osteosarcoma
![Page 49: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/49.jpg)
Metastatic melanoma
•Clin: Extrapulmonary 1° melanoma muchmore common than pulmonary 1°No known 1° in 510% of cases
•Path: Variable architecture & cytologyMay be pigmentedUse immunohistochemistry to confirm
![Page 50: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/50.jpg)
Metastatic melanoma
![Page 51: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/51.jpg)
Summary: Classification andMorphology of Lung Neoplasms
•1° Lung Neoplasms –Most are carcinomas–Small cell vs. Nonsmall cell carcinoma is a
major clinical distinction–New drug indications mandate distinction of
Squamous from Adenocarcinoma
•Metastases to Lung –All lineages possible
![Page 52: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/52.jpg)
What is the underlying sciencein this morphologic spectrum of
lung carcinomas?
![Page 53: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/53.jpg)
Epidemiology
![Page 54: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/54.jpg)
Adapted from Jemal, A et al CA Cancer J Clin 58: 71, 2008
MALES FEMALES
![Page 55: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/55.jpg)
Male Cancer Death Rates, 19302004
Annual Ageadjusted Cancer Death Rates
Adapted from CA Cancer J Clin 58: 71, 2008
![Page 56: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/56.jpg)
Female Cancer Death Rates, 19302004
Adapted from CA Cancer J Clin 58: 71, 2008
Annual Ageadjusted Cancer Death Rates
![Page 57: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/57.jpg)
Lung Carcinomas:Epidemiology
• Estimated Incidence (2008): 215,000 (US)• Estimated Mortality (2008): 162,000 (US)• >85% of lung carcinoma deaths (and 30% of all
cancer deaths) occur in cigarette smokers• Risk = f(# cigarettes smoked), 1530X in heavy
smokers, 5060X in asbestos workers who smoke• Risk decreases with cessation of cigarette smoking:
ca. 1.5X after 15 years
![Page 58: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/58.jpg)
SmokingAssociated Lung Diseases
• Anthracosis• Desquamative interstitial pneumonia• Chronic bronchitis• Emphysema → pulmonary arterial hypertension• Langerhans cell histiocytosis• Primary lung carcinomas –all except BAC• ENT squamous carcinoma metastatic to lung
![Page 59: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/59.jpg)
Benefits to the Lung of Smoking
![Page 60: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/60.jpg)
How does smoking cause lungcarcinomas?
![Page 61: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/61.jpg)
Tobacco: Chemistry
•Gases: CO, CO2, formaldehyde, acrolein,methanol, phenol, anthracenes, pyrenes
•Particulates:–resin cores in 0.5 µM diameter water droplets–est. 109 particles/ml–50% deposited in and cleared by cilia–remainder: phagocytosis, lymphatic transport
•Overall: 4,000 chemical compounds, ofwhich ca. 40 are considered carcinogenic
![Page 62: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/62.jpg)
Accumulation of Mutations
Kaccum = Kmut Krepair
Related to carcinogen dosei.e. pkyrs of smoke exposure
Related to DNA damagerepair capability
![Page 63: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/63.jpg)
Adapted from Carr, Science 300: 1512, 2003
DNA Damage Recognition Mechanisms
Mismatch Repair
![Page 64: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/64.jpg)
Associated Molecular Abnormalitiesand Potential Therapeutic Targets
Primary Lung Carcinomas
![Page 65: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/65.jpg)
Lung Squamous Carcinomas
Cytogenetic 3p del (RASSF1A, FHIT) 9p del (p16) 17p del (p53) Gene amp EGFR (30%)
Genetic p53 (6070%)
Epigenetic p16, FHIT (early methylation)
Protein Bcl2 overexpression (25%)
![Page 66: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/66.jpg)
Lung Adenocarcinoma (Smokers)
Cytogenetic Extensive amplifications and deletions Most common 14q amp, NKX2→ TTF1
Genetic KRAS mutations (1030%) P53 mutations (5070%)
Epigenetic p16 methylation assoc with KRAS
mutationsProtein
TTF1 overexpression (85%)
![Page 67: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/67.jpg)
Lung Adenocarcinoma (NonSmokers)
Cytogenetic EGFR amplification
Genetic EGFR mutation (1040%) KRAS mutation (1030%) Mutually exclusive
Epigenetic Lower methylation index
Protein +/ EGFR overexpression
![Page 68: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/68.jpg)
Small Cell Lung Carcinoma
Cytogenetic Extensive amps (e.g. Myc) and dels Del 3p (FHIT, VHL), 13q (Rb), 17p (p53)
Genetic Rb mutations P53 mutations
Epigenetic Methylation of CDH1 (Ecadherin)
Protein Bcl2, E2F1, telomerase overexpression
![Page 69: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/69.jpg)
Unknown Case
•59 y.o. exsmoker male with 6cm R hilar mass•Mediastinal and cervical lymphadenopathy•Bone and brain lesions•All lesions PET positive•Hard R cervical lymph node, for biopsy
![Page 70: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/70.jpg)
R Cervical LN Biopsy
![Page 71: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/71.jpg)
R Cervical LN Biopsy –CK7
![Page 72: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/72.jpg)
R Cervical LN Biopsy –CK20
![Page 73: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/73.jpg)
R Cervical LN Biopsy –TTF1
![Page 74: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/74.jpg)
R Cervical LN Biopsy –EGFR
![Page 75: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/75.jpg)
Morphologic Diagnosis
By H&E alone: Metastatic nonsmall cell carcinoma,poorly differentiated, favor ACa
H&E + IPOX: Metastatic ACa, poorly differentiated,consistent with lung primary EGFR 1+(of 3+), 2030% of ACa cells
![Page 76: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/76.jpg)
Exon 19 EGFRWildtype Sequence
Exon 19 EGFRPatient Sequence(delE746A750)
Molecular Data
Adapted from Shigematsu, JNCI 97: 339, 2005
![Page 77: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/77.jpg)
Adapted from Herbst et al, NEJM 359: 1367, 2008© 2008 Massachusetts Medical Society. All rights reserved.
EGFR Dimerization and Downstream Signaling
EGFR CellSignaling Pathways
![Page 78: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/78.jpg)
Adapted from Herbst et al, NEJM 359: 1367, 2008© 2008 Massachusetts Medical Society. All rights reserved.
EGFR Mutationsin NSCLC
![Page 79: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/79.jpg)
Adapted from Misudomi et al, Int J Clin Oncol 11: 190, 2006
Activating EGFRMutations
EGFR
![Page 80: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/80.jpg)
Mutations Also Predict Response toTyrosine Kinase Inhibitors (TKIs)
Adapted from Misudomi et al, Int J Clin Oncol 11: 190, 2006
Tum
or re
spon
se (%
) to
TKIs
![Page 81: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/81.jpg)
Adapted from Paez et al, Science 304: 1497, 2004
Model Structure of EGFR Kinase Domain
Del1 deletion: codons 746750
G719S
L858R
![Page 82: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/82.jpg)
EGFR MutantsCan TransformFibroblasts
Reproduced with permissionfrom Greulich et al, PLoS Med2:1167, 2005
![Page 83: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/83.jpg)
Reproduced with permission from Greulich et al, PLoS Med 2: 1167, 2005
EGFR Mutants are Active Tyr Kinaseswithout Ligand, i.e. Constitutively Activated
(Protein Immunoblot)
E19E20
![Page 84: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/84.jpg)
Most Activating EGFR MutationsAre Also Sensitive to TKI
Reproduced with permission from Greulich et al, PLoS Med 2: 1167, 2005
(E19)
![Page 85: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/85.jpg)
Predictive Variable:
Response toTaxol/CarboPt+/ TKIStratifies by EGFRMutation Status
Adapted from Eberhard et al, J Clin Onc 23: 5900, 2005
p<0.001
p>.05
![Page 86: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/86.jpg)
Screening for EGFR Mutations
![Page 87: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/87.jpg)
Different Amplicon Lengths AllowDetection of 15 bp Deletion in Exon 19
15 bp Deletion Wildtype Reproduced with permission fromPan et al, J Mol Diag 7: 396, 2005
![Page 88: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/88.jpg)
EGFR Exon 21 L858R Mutation AssayBased on RFLP Analysis
Reproduced with permission fromPan et al, J Mol Diag 7: 396, 2005
![Page 89: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/89.jpg)
Significance of KRAS Mutations
![Page 90: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/90.jpg)
Adapted from Eberhard, D et al J Clin Onc 2005; 23: 5900
Mutually Exclusive Relationship ofKRAS and EGFR in NSCLC
6337Indeterminate(n=46)
315046Wildtype(n=199)
1262Mutant (n=29)
EGFR (n=274)
Indeterminate(n=10)
WildType(n=209)
Mutant(n=55)
KRAS (n=274)
Summary of the EGFR and KRAS Mutational Analysis
![Page 91: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/91.jpg)
Reproduced with permission from Pao et al, PLoS Med 2: 57, 2005
KRAS Mutants are Not Sensitive to TKIs
![Page 92: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/92.jpg)
Molecular Diagnosis and Evaluationof the Current Case
•EGFR gene mutation present, del L746A750–Activating, would be TKI and
chemotherapy sensitive•KRAS not mutated
•Data predict that the patient should have anincreased survival with either TKI or taxane/Ptchemo.
![Page 93: Molecular€Pathobiology€of Lung€Canceraz9194.vo.msecnd.net/pdfs/090608/4.2.pdf · šLung€Anatomy šLung€Carcinoma€Classification€&€Morphology šLung€Carcinoma€Epidemiology](https://reader034.vdocuments.site/reader034/viewer/2022042311/5ed977291b54311e79679d12/html5/thumbnails/93.jpg)
Summary•Primary lung carcinoma is common and lethal•Most 1° lung carcinomas assoc with smoking•Different types treated differently•Understanding pathogenesis of different lung
carcinomas allows identification of new targets•EGFR/KRAS mutation screening can predict
response to tyrosine kinase inhibitors (TKIs)